![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
W Zheng, D Rampe and DJ Triggle
Department of Biochemical Pharmacology, School of Pharmacy, State University of New York, Buffalo 14260.
The pharmacological, radioligand binding, and electrophysiological properties of FPL 64176, a new nondihydropyridine Ca2+ channel activator, were studied in rat tail artery, cardiac membranes, and A7r5 smooth muscle cells. FPL 64176 induced a contractile response, with an EC50 value of 2.11 x 10(-7) M. The maximum tension response to FPL 64176 was approximately 2-fold higher than that to (S)-Bay K 8644. FPL 64176 showed no significant inhibitory activity at concentrations up to 10(-5) M. The Ca2+ channel antagonists nifedipine, verapamil and diltiazem noncompetitively antagonized and completely relaxed the responses induced by FPL 64176. IC50 values of these three drugs were 5.22 x 10(-9), 1.31 x 10(-7), and 1.95 x 10(-7) M, respectively, for relaxing submaximum contractile responses to FPL 64176 (5 x 10(-7) M). The washout time for FPL 64176 was about 40 min, which was much longer than that for (S)-Bay K 8644 (within 1 min). FPL 64176 weakly inhibited (+)-[3H]PN 200-110, [3H]D888, and [3H]TA-3090 binding in rat cardiac membranes, with IC50 values of 1.04 x 10(-5) M and 7.03 x 10(-6) M for inhibition of (+)-[3H]PN 200-110 and [3H]TA-3090 binding, respectively, and with 23% inhibition of [3H]D888 binding at a FPL 64176 concentration of 1 x 10(-5) M. Dissociation kinetics of the three radioligands were allosterically accelerated by FPL 64176. Electrophysiological studies on the A7r5 smooth muscle cell line directly confirmed a large (approximately 14-fold) stimulatory effect on L-type Ca2+ current amplitude. The results suggest that FPL 64176 is a new type of Ca2+ channel activator with higher efficacy and a mechanism and site of action that are distinct from those for (S)-Bay K 8644.
This article has been cited by other articles:
|
|
 |
|
  A. del Valle-Rodriguez, E. Calderon, M. Ruiz, A. Ordonez, J. Lopez-Barneo, and J. Urena Metabotropic Ca2+ channel-induced Ca2+ release and ATP-dependent facilitation of arterial myocyte contraction. PNAS, March 14, 2006; 103(11): 4316 - 4321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Lu and E. W Rubel Activation of Metabotropic Glutamate Receptors Inhibits High-Voltage-Gated Calcium Channel Currents of Chicken Nucleus Magnocellularis Neurons J Neurophysiol, March 1, 2005; 93(3): 1418 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. McDonough, Y. Mori, and B. P. Bean FPL 64176 Modification of CaV1.2 L-Type Calcium Channels: Dissociation of Effects on Ionic Current and Gating Current Biophys. J., January 1, 2005; 88(1): 211 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Carraway, S. Hassan, and D. E. Cochrane Polyphenolic Antioxidants Mimic the Effects of 1,4-Dihydropyridines on Neurotensin Receptor Function in PC3 Cells J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 92 - 101. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Yamaguchi, B. S. Zhorov, K. Yoshioka, T. Nagao, H. Ichijo, and S. Adachi-Akahane Key Roles of Phe1112 and Ser1115 in the Pore-Forming IIIS5-S6 Linker of L-Type Ca2+ Channel {alpha}1C Subunit (CaV 1.2) in Binding of Dihydropyridines and Action of Ca2+ Channel Agonists Mol. Pharmacol., August 1, 2003; 64(2): 235 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Wasserstrom, L. A. Wasserstrom, A. J. Lokuta, J. E. Kelly, S. T. Reddy, and A. J. Frank Activation of cardiac ryanodine receptors by the calcium channel agonist FPL-64176 Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H331 - H338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Katoh, K. Schlotthauer, and D. M. Bers Transmission of Information From Cardiac Dihydropyridine Receptor to Ryanodine Receptor : Evidence From BayK 8644 Effects on Resting Ca2+ Sparks Circ. Res., July 21, 2000; 87(2): 106 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Schjott and M. R. Plummer Sustained Activation of Hippocampal Lp-Type Voltage-Gated Calcium Channels by Tetanic Stimulation J. Neurosci., July 1, 2000; 20(13): 4786 - 4797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Jinnah, S. Yitta, T. Drew, B. S. Kim, J. E. Visser, and J. D. Rothstein Calcium channel activation and self-biting in mice PNAS, December 21, 1999; 96(26): 15228 - 15232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Shapiro, M. D. Loose, S. E. Hamilton, N. M. Nathanson, J. Gomeza, J. Wess, and B. Hille Assignment of muscarinic receptor subtypes mediating G-protein modulation of Ca2+ channels by using knockout mice PNAS, September 14, 1999; 96(19): 10899 - 10904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Johnson, C. S. Hill, S. Chawla, R. Treisman, and H. Bading Calcium Controls Gene Expression via Three Distinct Pathways That Can Function Independently of the Ras/Mitogen-Activated Protein Kinases (ERKs) Signaling Cascade J. Neurosci., August 15, 1997; 17(16): 6189 - 6202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-W. Jeong and R. D. Wurster Calcium Channel Currents in Acutely Dissociated Intracardiac Neurons From Adult Rats J Neurophysiol, April 1, 1997; 77(4): 1769 - 1778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Z. Peterson, T. N. Tanada, and W. A. Catterall Molecular Determinants of High Affinity Dihydropyridine Binding in L-type Calcium Channels J. Biol. Chem., March 8, 1996; 271(10): 5293 - 5296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Malgaroli, A. Ting, B Wendland, A Bergamaschi, A Villa, R. Tsien, and R. Scheller Presynaptic component of long-term potentiation visualized at individual hippocampal synapses Science, June 16, 1995; 268(5217): 1624 - 1628. [Abstract] [PDF]
|
|
|
|
|
|
S. Yamaguchi, Y. Okamura, T. Nagao, and S. Adachi-Akahane Serine Residue in the IIIS5-S6 Linker of the L-type Ca2+ Channel alpha 1C Subunit Is the Critical Determinant of the Action of Dihydropyridine Ca2+ Channel Agonists J. Biol. Chem., December 22, 2000; 275(52): 41504 - 41511. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
